Press Release

01 November
2022

Hilleman Laboratories to Develop A Thermostable Second-Generation Zaire Ebolavirus Vaccine In Collaboration with MSD

Read More
27 October
2022

SK bioscience and Hilleman Laboratories to Co-develop New Vaccine Platforms

Read More
04 October
2022

International Vaccine Institute signs Memorandum of Understanding with Hilleman Laboratories to advance vaccine R&D and manufacturing for safe, effective, and affordable vaccines in low-and middle-income countries

Read More
22 February
2022

Hilleman Laboratories breaks ground on pilot cGMP facility for vaccine development

Read More
06 December
2021

Hilleman Laboratories establishes pilot manufacturing facility for vaccine development in Singapore with support from Singapore Economic Development Board

Read More